| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 1751 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| poloxamer 188 | POLOXAMER 188 | LQA7B6G8JG | INJECTION / INTRAVENOUS | 6 mg | | Exact identifier — unii+route 6 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 1800 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+dosage form 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 1751 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 13.2 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+dosage form 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 1800 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| maltose monohydrate | MALTOSE MONOHYDRATE | DM477EE40D | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 300 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 1800 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic, monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 15.55 mg | | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 13.2 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic, monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 15.55 mg | | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic, monohydrate | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 593YOG76RN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 15.55 mg | | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| maltose monohydrate | MALTOSE MONOHYDRATE | DM477EE40D | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 300 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| poloxamer 188 | POLOXAMER 188 | LQA7B6G8JG | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2.2 mg | | Exact identifier — unii+route 6 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION / INTRAVENOUS | | 161 mg | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.07 %w/v | | Exact identifier — unii+route 31 equally ranked IID candidates |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | INJECTION, SOLUTION / SUBCUTANEOUS | 0.11 %w/v | | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | | 1486 mg | Exact identifier — unii+route+dosage form 14 equally ranked IID candidates |
| sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 2000 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION / INTRAVENOUS | | 161 mg | Exact identifier — unii+route 31 equally ranked IID candidates |
| poloxamer 188 | POLOXAMER 188 | LQA7B6G8JG | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2.2 mg | | Exact identifier — unii+route 6 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION / INTRAVENOUS | | 161 mg | Exact identifier — unii+route 31 equally ranked IID candidates |
| sodium phosphate, monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 0.22 mg | | Exact identifier — unii+dosage form 31 equally ranked IID candidates |
| sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | | 2000 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |